Instruments, modules, and methods for improved detection of edited sequences in live cells

US11046928B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11046928-B2
Application numberUS-202017102414-A
CountryUS
Kind codeB2
Filing dateNov 23, 2020
Priority dateAug 14, 2018
Publication dateJun 29, 2021
Grant dateJun 29, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.

First claim

Opening claim text (preview).

We claim: 1. A method for enriching edited cells during nucleic acid-guided CRISPR nuclease editing comprising: diluting a population of cells into groups of 2 to 100 cells thereby generating substantially singulated groups of cells, wherein each cell comprises a promoter driving expression of a coding sequence for a nucleic acid-guided nuclease and a promoter driving expression of a guide nucleic acid; growing the cells in the substantially singulated groups of cells; initiating editing of the cells in the substantially singulated groups of cells by inducing transcription of one or both of the nucleic acid-guided nuclease and the guide nucleic acid; growing the edited cells in the substantially singulated groups of cells on a substrate until the edited cells in the substantially singulated groups of cells establish colonies of terminal size. 2. The method of claim 1 , wherein the same inducible promoter drives transcription of both of the gRNA and the nuclease. 3. The method of claim 1 , wherein the population of cells is diluted into groups of 2 to 50 cells. 4. The method of claim 1 , wherein the population of cells is diluted into groups of 2 to 10 cells. 5. The method of claim 1 , wherein the inducing transcription comprises inducing one or more temperature inducible promoter. 6. The method of claim 1 , wherein the inducing transcription comprises inducing one or more pBAD promoter(s). 7. The method of claim 1 , wherein cells in the substantially singulated groups of cells further comprise a nucleic acid sequence for a donor nucleic acid. 8. The method of claim 7 , wherein the donor nucleic acid is covalently linked to the guide nucleic acid. 9. The method of claim 8 , wherein the device with solid walls is a solid wall isolation, induction, and normalization (SWIIN) device. 10. The method of claim 7 , wherein the nucleic acid sequence for the donor nucleic acid encodes a promoter sequence for a promoter swap. 11. The method of claim 1 , wherein the edited cells are bacterial cells, mammalian cells, or yeast cells. 12. The method of claim 1 , wherein the substrate is selected from an agar plate and a device with solid walls. 13. A method for enriching edited cells during nucleic acid-guided CRISPR nuclease editing comprising: diluting a populations of cells into groups of 2 to 100 cells thereby generating substantially singulated groups of cells, wherein the cells comprise a promoter driving expression of a coding sequence for a nucleic acid-guided nuclease and a promoter driving expression of a guide nucleic acid; growing the cells in the substantially singulated groups of cells on a substrate; initiating editing of cells in the substantially singulated groups of cells by inducing transcription of one or both of the nucleic acid-guided nuclease and the guide nucleic acid; growing the substantially singulated groups of cells on the substrate then selecting slow-growing colonies. 14. The method of claim 13 , wherein the same inducible promoter drives transcription of both of the gRNA and the nuclease. 15. The method of claim 13 , wherein the population of cells is diluted into groups of 2 to 50 cells. 16. The method of claim 13 , wherein the population of cells is diluted into groups of 2 to 10 cells. 17. The method of claim 13 , wherein the inducing transcription comprises inducing one or more temperature inducible promoter. 18. The method of claim 13 , wherein cells in the substantially singulated groups of cells further comprise a nucleic acid sequence for a donor nucleic acid. 19. The method of claim 18 , wherein the nucleic acid sequence for the donor nucleic acid encodes a promoter sequence for a promoter swap. 20. The method of claim 13 , wherein the edited cells are bacterial cells, mammalian cells, or yeast (Original) cells.

Assignees

Inventors

Classifications

  • Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title

  • Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation · CPC title

  • Mutagenizing nucleic acids · CPC title

  • C12N9/22Primary

    Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • C12M47/04Primary

    Cell isolation or sorting (purging biological preparations of unwanted cells C12N5/0081, determining the presence or kind of microorganism C12Q1/04) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11046928B2 cover?
The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.
Who is the assignee on this patent?
Inscripta Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).